Edition:
India

Fujifilm Holdings Corp (4901.T)

4901.T on Tokyo Stock Exchange

4,592JPY
19 Aug 2019
Change (% chg)

-- (--)
Prev Close
¥4,592
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,312,164
52-wk High
¥5,618
52-wk Low
¥4,025

Latest Key Developments (Source: Significant Developments)

Fujifilm To Buy Back Up To 3.18% Of Shares Worth 50 Billion Yen Through March 31, 2020
Thursday, 8 Aug 2019 

Aug 8 (Reuters) - Fujifilm Holdings Corp <4901.T>::TO BUY BACK UP TO 3.18% OF SHARES WORTH 50 BILLION YEN THROUGH MARCH 31, 2020.  Full Article

Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerod, Denmark to Fujifilm
Tuesday, 12 Mar 2019 

March 12 (Reuters) - Biogen Inc ::BIOGEN EXPECTS NEW MANUFACTURING FACILITY IN SOLOTHURN, SWITZERLAND TO BE OPERATIONAL BY END OF 2020.BIOGEN ENTERS INTO AN AGREEMENT TO SELL ITS LARGE-SCALE BIOLOGICS MANUFACTURING SITE IN HILLERØD, DENMARK TO FUJIFILM.BIOGEN WILL ENTER INTO MANUFACTURING SERVICES AGREEMENTSWITH FUJIFILM TO SUPPLY TYSABRI AND THIRD-PARTY PRODUCTS.BIOGEN EXPECTS NEW MANUFACTURING FACILITY IN SOLOTHURN, SWITZERLAND TO BE OPERATIONAL BY END OF 2020.BIOGEN- EXPECTS TO RECORD TOTAL AFTER-TAX LOSS IN Q1 2019 OF ABOUT $130 MILLION TO $150 MILLION, OR $0.66 TO $0.76 PER DILUTED SHARE, RELATED TO PROPOSED TRANSACTION.  Full Article

R&I affirms Fujifilm Holdings's rating at "AA" and announces stable outlook -R&I
Thursday, 15 Nov 2018 

Nov 15(Reuters) - Fujifilm Holdings Corp <4901.T>:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA" -R&I.Rating outlook stable -R&I.  Full Article

Mylan Says Non-Contingent Payments For 4 Agreements Total About $265 Mln
Friday, 11 May 2018 

May 10 (Reuters) - Kyowa Hakko Kirin Co Ltd <4151.T>::MYLAN NV - NON-CONTINGENT PAYMENTS FOR 4 AGREEMENTS, 3 OF WHICH WERE ENTERED INTO AFTER MARCH 31, 2018, TOTAL ABOUT $265.0 MILLION - SEC FILING.MYLAN-ON APRIL 9, A UNIT RECEIVED CIVIL INVESTIGATIVE DEMAND FROM COMMERCIAL LITIGATION BRANCH OF U.S. DOJ CONCERNING TAA COMPLIANCE FOR SOME PRODUCTS.MYLAN - ON APRIL 18, SOME EMPLOYEES OF MYLAN S.P.A. WERE SERVED WITH SEARCH WARRANTS ISSUED BY PUBLIC PROSECUTOR’S OFFICE IN MILAN, ITALY.MYLAN-WARRANTS BY MILAN PUBLIC PROSECUTOR’S OFFICE SEEK INFORMATION ON INTERACTIONS WITH ITALIAN HOSPITAL, SALES OF SOME REIMBURSABLE MYLAN S.P.A. DRUGS.  Full Article

Fujifilm confident it will win an appeal to remove block to deal with Xerox
Tuesday, 8 May 2018 

May 8 (Reuters) - Fujifilm Holdings Corp <4901.T>::FUJIFILM SAYS IT IS CONFIDENT THAT IT WILL WIN APPEAL TO REMOVE BLOCK TO DEAL WITH XEROX.  Full Article

Xerox Reaches Agreement With Carl Icahn And Darwin Deason
Wednesday, 2 May 2018 

May 1 (Reuters) - Xerox Corp ::XEROX REACHES AGREEMENT WITH CARL ICAHN AND DARWIN DEASON.SAYS XEROX SETTLES PENDING PROXY CONTEST AND LITIGATION; NO EFFECT ON PENDING CLAIMS AGAINST FUJIFILM.JOHN VISENTIN TO BE NAMED VICE CHAIRMAN AND CHIEF EXECUTIVE OFFICER.SAYS NEW BOARD TO MEET IMMEDIATELY TO DISCUSS STRATEGIC ALTERNATIVES.SAYS KEITH COZZA OF ICAHN ENTERPRISES TO BE NAMED CHAIRMAN.SAYS XEROX WILL APPOINT SIX NEW MEMBERS TO ITS BOARD OF DIRECTORS.AGREEMENT WILL AUTOMATICALLY TERMINATE IF COURT DOES NOT ACT BEFORE 8:00 P.M. ET ON MAY 3, 2018.SAYS JEFF JACOBSON WILL RESIGN AS CHIEF EXECUTIVE OFFICER OF XEROX AND AS A MEMBER OF ITS BOARD OF DIRECTORS.  Full Article

1 Production Film says no dividend payment for 2017
Friday, 23 Mar 2018 

March 23 (Reuters) - 1 Production Film Co <8458.TWO>:Says it will pay no dividend to shareholders for 2017.  Full Article

Cosmo Pharmaceuticals And FUJIFILM Expand Distribution Agreement For Eleview
Tuesday, 13 Mar 2018 

March 13 (Reuters) - COSMO PHARMACEUTICALS NV ::COSMO PHARMACEUTICALS AND FUJIFILM EXPAND DISTRIBUTION AGREEMENT FOR ELEVIEW.  Full Article

U.S. FDA Issues Warning Letters To Duodenoscope Manufacturers, Olympus, Fujifilm And Pentax
Friday, 9 Mar 2018 

March 9 (Reuters) - Fujifilm Holdings Corp <4901.T>::U.S. FDA SAYS ISSUED WARNING LETTERS TO DUODENOSCOPE MANUFACTURERS, OLYMPUS, FUJIFILM, PENTAX FOR FAILING TO COMPLY WITH REQUIREMENTS OF FEDERAL LAW.U.S. FDA - AS PER FEDERAL LAW REQUIREMENTS THE MANUFACTURERS WERE TO CONDUCT POSTMARKET STUDIES TO ASSESS EFFECTIVENESS OF REPROCESSING DUODENOSCOPES.U.S. FDA - EXPECTS OLYMPUS, FUJIFILM, PENTAX TO SUBMIT A PLAN BY MARCH 24 OUTLINING HOW THE POSTMARKET SURVEILLANCE STUDY MILESTONES WILL BE ACHIEVED.  Full Article

Darwin Deason Files Lawsuit Against Xerox, Fujifilm Holdings Corp
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - :DARWIN DEASON SAYS HAS FILED LAWSUIT AGAINST FUJIFILM HOLDINGS CORP, XEROX, CURRENT XEROX BOARD MEMBERS, & URSULA BURNS, XEROX'S FORMER CHAIRMAN & CEO.DARWIN DEASON SAYS THE COMPLAINT WAS FILED ON FEBRUARY 13, 2018, IN SUPREME COURT OF STATE OF NEW YORK, NEW YORK COUNTY.DARWIN DEASON SAYS IN COMPLAINT, DEASON SEEKS TO ENJOIN DEAL, TERMINATE XEROX/FUJI JV LOCK-UP, JV AGREEMENTS & PURSUE STRATEGIC ALTERNATIVES FOR XEROX.  Full Article

Photo

Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business

TOKYO Japan's Fujifilm Holdings Corp will buy a drugmaking business from U.S.-based Biogen Inc for about $890 million to try to bolster its healthcare business as growth at its legacy photocopy operations stagnates.